Profile: Targeted Genetics Corporation discovers, develops & delivers molecular medicines to treat and prevent diseases with significant unmet medical need. We focus on the development of product candidates to treat inflammatory arthritis & eye disease, HIV/AIDS vaccines and congestive heart failure. We develop an AAV-based product candidate (tgAAC94) for inflammatory arthritis that is designed to deliver a potent inhibitor of tumor necrosis factor alpha, a key mediator of inflammation.